Flag of the European Union EU Clinical Trials Register Help

Clinical trials for SIDD

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44380   clinical trials with a EudraCT protocol, of which   7392   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    Query did not match any clinical trials.
    These are paediatric studies completed by 26 January 2007, in respect of products authorised in the Community (Article 45 of the Paediatric Regulation (EC) No 1901/2006).
    Note: Advanced search filters for country, trial phase, gender, rare disease, IMP with orphan designation in the indication and age ranges of in-utero, adult or elderly do not apply to these records.
    Study title: Cory DA, Siddiqui AR, Cohen MD. Uptake of technetium 99m MDP by hepatoblastoma. Eur J Nucl Med. 1987;12(11):546-7. Cory DA, Siddiqui AR, Cohen MD. Uptake of technetium 99m MDP by hepatoblastoma. Eur J Nucl Med. 1987;12(11):546-7.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43885
    Study title: Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8. Charkes ND, Siddhivarn N, Schneck CD. Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). J Nucl Med. 1987 Dec;28(12):1835-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43839
    Study title: Computerized skeletal scintigraphy for assessment of mandibular asymmetry. Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med 1987 Dec;28{12):1835-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48470
    Study title: Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515. Naik HR, Siddique N, Chandrasekar PH. Foscarnet therapy for acyclovir resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients. Clinical Infectious Diseases 1995; 21(6):1514-1515.
    Active substance: Foscarnet
    Study summary document link (including results): Naik HR et al 1995.pdf
    View full study record
    Document reference: 39674
    Study title: Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med. 1987 Dec;28(12):1835-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48839
    Study title: The role of bone scintigraphy in osteogenic sarcoma. Rees CR, Siddiqui AR, duCret R. Skeletal Radiol. 1986;15(5):365-7.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43924
    Study title: Park HM, Hunt-Reimann A, Appledorn CR, Siddiqui A. A comet-tail imaging artifact. Due to a "hot" point source and faulty electronics. Clin Nucl Med. 1993 Apr;18(4):341-2. No abstract available. Park HM, Hunt-Reimann A, Appledorn CR, Siddiqui A. A comet-tail imaging artifact. Due to a "hot" point source and faulty electronics. Clin Nucl Med. 1993 Apr;18(4):341-2. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43669
    Study title: Single dose pharmacokinetics of sulfadoxine, pyrimethamine and mefloquine in thai children following administration of one tablet Fansimef, Schwartz D E*,Weidekamm E,Heizmann P,Chongsuphajaisiddhi T,Portmann R
    Active substance: MEFLOQUINE
    Study summary document link (including results):
    View full study record
    Document reference: 31586
    Study title: Siddiqui AH. Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen, Arch Dermatol Res. 1984;276(5):343-5.Siddiqui AH. Comparison of serum levels and clinical results of PUVA therapy with three different dosage forms of 8-methoxypsoralen, Arch Dermatol Res. 1984;276(5):343-5.
    Active substance: METHOZSALEN
    Study summary document link (including results):
    View full study record
    Document reference: 31719
    Study title: Abdominal masses in children: multiorgan imaging with 99mTc methylene diphosphonate. Siddiqui AR, Cohen M, Moran DP. AJR Am J Roentgenol. 1982 Jul;139(1):35-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44079
    Study title: "Cold spot" on bone scan at the site of primary osteosarcoma. Siddiqui AR, Ellis JH. Eur J Nucl Med. 1982;7(10):480-1.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44098
    Study title: Nuclear medicine studies in evaluation of skeletal lesions in children with histiocytosis X. Siddiqui AR, Tashjian JH, Lazarus K, Wellman HN, Baehner RL. Radiology. 1981 Sep;140(3):787-9.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44111
    Study title: Siddiqui AR. Increased uptake of technetium-99m-labeled bone imaging agents in the kidneys. Semin Nucl Med. 1982 Jan;12(1):101-2. No abstract available. Siddiqui AR. Increased uptake of technetium-99m-labeled bone imaging agents in the kidneys. Semin Nucl Med. 1982 Jan;12(1):101-2. No abstract available.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 44105
    Study title: Martin-Simmerman P, Cohen MD, Siddiqui A, Mirkin D, Provisor A. Calcification and uptake of Tc-99m diphosphonates in neuroblastomas: concise communication. J Nucl Med. 1984 Jun;25(6):656-60. Martin-Simmerman P, Cohen MD, Siddiqui A, Mirkin D, Provisor A. Calcification and uptake of Tc-99m diphosphonates in neuroblastomas: concise communication. J Nucl Med. 1984 Jun;25(6):656-60.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 43997
    Study title: Bone scanning in the adductor insertion avulsion syndrome ("thigh splints"). Charkes ND, Siddhivarn N, Schneck CD. J Nucl Med 1987 Dec;28{12):1835-8.
    Active substance: TECHNETIUM (99mTc) MEDRONIC ACID
    Study summary document link (including results):
    View full study record
    Document reference: 48469
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu Feb 12 06:44:13 CET 2026 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA